PTX3 expression is silenced through promoter hypermethylation in different types of cancers [10,12] and may act as an oncosuppressor by modulating tumor-associated inflammation [12] and/or by blocking protumor growth factors like various members of the FGF family [11]. This evidence concerns the gene PTX3 and cancer.